Background: Few data exist on the serologic outcome of treponemal tests in congenital syphilis. Methods: a chart review was conducted on all confirmed early congenital syphilis cases in edmonton, Canada, from 2005-2010. Results: Of the 16 cases identified, 11 (69%) infants seroreverted their treponemal tests by 18 months. Cases that did not serorevert their treponemal tests were statistically more likely to have delayed treatment and to have higher maternal rapid plasma reagin titers at birth. Conclusions: Our data suggest that the majority of early congenital syphilis cases will serorevert their treponemal tests by 18 months.
arly congenital syphilis is nationally notifiable in Canada. in the western Canadian province of alberta, the first case of early congenital syphilis in over 10 years was reported in 2002 after the resurgence of locally acquired infectious syphilis in 2000. 1 in northern alberta, this rise has been observed predominantly among heterosexual persons with the majority of congenital cases born to mothers with little or no prenatal care. this geographic area has seen the largest incidence of early congenital syphilis cases in Canada over the last decade. 2 Because many infants with congenital syphilis are asymptomatic at birth, serologic tests remain the mainstay of diagnosis, but interpretation is complicated by the passive transfer of maternal antibodies (treponemal and nontreponemal) to the infant. the objective of this study was to examine the incidence and factors associated with seroreversion of syphilis treponemal tests (tts) in infants born in edmonton, alberta, who met Canadian surveillance criteria for confirmed early congenital syphilis.
MATERIALS AND METHODS

Canadian Surveillance Criteria for Congenital Syphilis
Congenital syphilis is divided into 2 clinical syndromes: early (diagnosis during first 2 years of life including stillbirths) and late (after 2 years of age). Only early congenital syphilis is nationally notifiable in Canada.
Confirmed (the term "confirmed" refers to the surveillance definition of a case) case-early Congenital syphilis (within 2 years of birth):
laboratory confirmation of infection:
• identification of Treponema pallidum by dark-field microscopy, fluorescent antibody, polymerase chain reaction or equivalent examination of material from nasal discharges, skin lesions, placenta, umbilical cord or autopsy material of a neonate (up to 4 weeks of age) Or • reactive serology (nontreponemal and treponemal) from venous blood (not cord blood) in an infant/child with clinical, laboratory or radiographic evidence of congenital syphilis (includes any evidence of congenital syphilis on physical examination (eg, hepatosplenomegaly), evidence of congenital syphilis on radiographs of long bones, a reactive cerebrospinal fluid (CsF) Venereal disease research laboratory, an elevated CsF cell count or protein without other cause) whose mother is without documented evidence of adequate treatment Or • detection of T. pallidum dna in an appropriate clinical specimen Methods under alberta's Public Health act, maternal stage of syphilis, treatment information and serologic follow-up as well as infant clinical, laboratory and treatment information are obtained and stored in a provincial sexually transmitted infection database. all reactive syphilis tests are reported to alberta Health services sexually transmitted infections services by laboratories as well as by testing physicians/providers. all cases meeting Canadian surveillance criteria for confirmed early congenital syphilis in edmonton, the provincial capital located in northern alberta, from 2005 to 2010 were extracted from the provincial database and chart reviews conducted of all cases.
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no intrauterine abnormalities are treated with intramuscular benzathine penicillin g-long acting 2.4 million units weekly for 2 doses. 4 Before september 2007, infants being investigated for syphilis were screened with a rapid plasma reagin (rPr; Bd Macro-Vue™ rPr test, Becton dickinson Microbiology systems, Ontario, Canada) with or without a T. pallidum particle agglutination and/or fluorescent treponemal antibody absorbed (Fta-aBs). On september 1, 2007, a reverse sequence syphilis screening algorithm was introduced province-wide with the initial syphilis serologic screen with a syphilis enzyme immunoassay (eia; architect syphilis tP Chemiluminescent Microparticle immunoassay, abbott laboratories, abbott Park, il). a positive eia is followed by a quantitative rPr and a second or supplementary tt with a syphilis innO-lia™ (innO-lia™ syphilis, innogenetics nV, ghent, Belgium). 5, 6 after the syphilis innO-lia™ is confirmed as positive in a patient, this test is no longer repeated; repeat syphilis testing is with a syphilis eia followed by a quantitative rPr. the timing and frequency of follow-up syphilis serologic testing in infants varies depending on recommendations from pediatric specialists and individual compliance with follow-up.
Bone radiographs were reviewed by pediatric radiologists and determined to be consistent with congenital syphilis if they demonstrated changes of osteochondritis or perichondritis. 7 CsF was considered abnormal if CsF white blood cell counts was >10 × 10 6 /l, CsF protein was >0.45 g/l, CsF glucose was <2.2 mmol/l and/or CsF Venereal disease research laboratory was reactive. anemia was defined as hemoglobin <120 g/l. all infants <1 month of age were treated with crystalline penicillin g 50,000 units/kg iv every 12 hours for the first week of life and then every 8 hours thereafter for 10 days of total therapy. 4 infants ≥1 month of age received crystalline penicillin g 50,000 units/kg iv every 6 hours for 10-14 days. 4 Categorical variables were compared between infants who seroreverted and those who remained tt positive using Fisher exact test (stata 10, statacorp, College station, tX). Maternal rPr was compared between groups using a Wilcoxon-type test for trend. 8 ethics approval was obtained from the university of alberta Health research ethics Board.
RESULTS
From 2005 through 2010, 22 infants met Canadian surveillance criteria for confirmed congenital syphilis in edmonton, Canada, of which 6 were stillborn or deceased within a week of birth. no mothers or infants were coinfected with HiV. table, supplemental digital Content 1, http://links.lww.com/inF/B349 provides the maternal and infant case pair details on congenital syphilis cases with nonreactive tts at the end of the follow-up period, whereas table 1 provides the maternal and infant case pairs details on congenital syphilis cases with persistently reactive tts at the end of the follow-up period. all infants were followed until seroreversion of serum tts or for a minimum of 18 months if they did not serorevert; all had complete follow-up. table 2 summarizes the data from the 16 survivors who had a median follow-up period of 18.5 months (range 5-73 months). the majority of mothers (68.6%; n = 11) were treated after delivery, 4 mothers were treated during pregnancy and the remaining mother was treated at the time of delivery. Of the 4 mothers treated during pregnancy, 2 were treated with iv penicillin at 28 and 34 weeks gestation, respectively, and 2 were treated with 2 weekly doses of intramuscular benzathine penicillin g-long acting 2.4 million units (1 case at 10/11 and 18/19 weeks because of suspected reinfection and 1 case at 20 weeks gestation). thirteen (81.3%) of the infants were treated with iv penicillin within 2 days of birth, and the remaining 3 received treatment at 2, 3 and 8 months of age, respectively. the 3 infants in whom there was a significant delay in diagnosis (cases 1, 3 and 4 in table 1) were all born to mothers who tested negative during a first trimester screen but acquired the infection near term and were not retested at the time of delivery. due to a low index of suspicion for syphilis during the early stages of resurgence of infectious syphilis in alberta, there was a significant delay in diagnosis in cases 1 and 3 despite the presence of characteristic signs of congenital syphilis (anemia, hepatosplenomegaly and desquamating rash); both infants were initially thought to possibly have juvenile myelomonocytic leukemia.
eleven cases (68.8%) seroreverted their tt at the end of their follow-up period (median 14 months, range 5-73 months). Of these 11 cases, 9 tested negative by syphilis eia and 2 by T. pallidum particle agglutination and/or Fta-aBs. three of the 5 cases who did not serorevert their tt (follow-up range 18-56 months) had delayed treatment (at 2, 3 and 8 months of age) versus none of the cases who seroreverted their tt (P = 0.02; 0% versus 60%). the maternal rPr titers at delivery were significantly higher for the 5 cases who did not serorevert as compared with the seroreverted cases. all 5 cases who did not serorevert had maternal rPrs of 1:128 or higher compared with only 3 of the 11 cases (27.3%) who seroreverted (P = 0.03). infants with anemia (P = 0.01) and rash (P = 0.003) were also significantly less likely to serorevert their tt.
due to technical difficulties (mostly bloody CsF), CsF Venereal disease research laboratory was not performed in 4 of 15 cases and no lumbar puncture was done in 1 case.
DISCUSSION
serologic results in infants born to mothers with reactive syphilis serology need to be interpreted together with maternal history, physical examination and investigations in the infant. 7 as in other stages of syphilis, tts in congenital cases can remain positive indefinitely despite effective treatment but few data exist on seroreversion. Passively transferred tts can persist in an infant up to age 18 months and a reactive tt after age 18 months is diagnostic of early congenital syphilis; such infants require full evaluation and treatment for congenital syphilis if treatment was not provided or deemed inadequate by history. 9 seroreversion to nonreactive tts has been observed after 2-3 years in 15%-25% of adults treated during the primary stage of syphilis.
10 a study using Fta-aBs suggested that the same may be true for congenital syphilis as only about onehalf of the infants with clinical or laboratory evidence of congenital syphilis at birth had reactive Fta-aBs at 12 month of age. 11 in our case series, 68.8% of early congenital syphilis cases with complete follow-up seroreverted their tt by age 18 months, suggesting higher seroreversion rates than previously reported. seroreversion was observed with traditional tts such as T. pallidum particle agglutination and Fta-aBs as well as newer tt (eia). although our case numbers are small, our data suggest seroreversion in cases treated earlier: all cases treated in utero (n = 4) and at or near birth (n = 7) seroreverted their serology. seroreversion of tt serology was also statistically associated with lower maternal rPr titers at delivery. the 3 cases where the infant treatment was delayed for 2-8 months after birth and 2 cases where treatment was administered at birth did not serorevert. these cases highlight the importance of syphilis screening or rescreening in the mother at the time of delivery to assess for the possibility of infection or reinfection near term. this is especially important in areas experiencing a resurgence of heterosexually acquired infectious syphilis. in one of our cases, the mother had a new partner near term, and in another, the mother did not report personal risk factors for syphilis and was unaware of her partner's risks. Our data also highlight the need for a high index of suspicion for congenital syphilis in areas where syphilis is endemic and also in areas experiencing a resurgence; in the latter, 2# (66.7) 0.5 *P value calculated by Fisher exact test, except for maternal RPR titers where a nonparametric test for trend was used. 5 Bolded text indicates P values < 0.05. †Infants also received treatment at birth. ‡No CSF VDRL result for 2 nonreactive cases and 2 reactive cases (no CSF obtained in 1 nonreactive case). §Only 1 nonreactive infant had PCR performed (using intrauterine blood from fetal portal vein). ¶Only 2 reactive infants had syphilis PCR performed (using umbilical cord and skin blister).
‖Only 1 infant had positive direct fluorescent antibody performed; therefore, no P value was calculated. #Only 9 reactive infants and 3 nonreactive infants had radiographic examination. RPR indicates rapid plasma reagin; PCR, polymerase chain reaction.
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early communication with healthcare providers to raise awareness of the resurgence of infectious and congenital syphilis and their clinical manifestations is critical. a 4-fold or higher titer in the infant's serum at delivery compared with the mother's titer is strongly suggestive of congenital infection. 12 However, of interest in our case series, only 1 of 16 infant rPr titers was 4-fold greater than the mother (table 1, case 5 where maternal rPr titer 1:128 and infant rPr titer 1:512 at birth); of note, this case did not serorevert their tt, thus confirming the diagnosis of congenital syphilis. a cases series by rawstron et al 11 reported that <30% of infants with congenital syphilis have higher titers than their mothers and as such the absence of an infant's titer that is 4-fold or greater than the mother's titer does not exclude congenital infection.
Our case series had complete follow-up of all mothers and infants by specialists in the management of adult and pediatric syphilis in the setting of publicly funded healthcare services. serologic testing was ensured by close follow-up by public health nurses. some of the limitations of our data include that this is an observational cohort of a relatively small number of infants. although all cases met Canadian surveillance criteria for congenital syphilis, direct diagnostic tests (eg, polymerase chain reaction for syphilis) were only conducted in a few cases (n = 3) because of the limited availability of these tests during the early period of resurgence of infectious syphilis in alberta. it is always possible that an alternate diagnosis exists for some of these cases. this is unlikely, however, given that 1 of the 11 cases who had seroreverted were diagnosed with congenital syphilis on the basis of positive syphilis polymerase chain reaction of fetal blood and 7 cases were born to mothers with infectious (primary/secondary/early latent) syphilis who were untreated until at or after delivery; 3 infants had fetal hydrops, 2 had abnormal long bone radiographs; 1 had edema and ascites; and the remaining 5 had abnormal CsF indices.
Because the sample collection time points were not standardized among the exposed infants, we cannot make firm recommendations on optimal time points and frequency of follow-up serology from our data. Canadian and u.s. Centers for disease Control and Prevention guidelines recommend follow-up serology and indicate that loss of treponemal antibodies should be expected by 18 months in infants without congenital syphilis or with treatment early after congenital infection. 7, 13 in summary, our data suggest that the majority of cases of congenital syphilis will serorevert their tts by 18 months. seroreversion occurs with traditional tts as well as newer tts like eia. Our data suggesting seroreversion in cases treated earlier and with lower maternal rPr titers at delivery should ideally be confirmed in larger case series.
